انا جمعت احدث واهم الادوية اللى اتسحبت واللى اكتشف ليها اعراض جانبية جديدة وتم التنبيه عليها وايه الاسباب او الاعراض الجانبية اللى اتسحب عشانها .
مثلا سيبوترامين اتسحب عشان خطورته ع القلب
وفى حاجات ما اتسحبتش بس اكتشفولها خطوره
مثال فوزاماكس بيعالج هشاشة العظام اكتشفو انه بيعمل كسور فى عظام الفخذ
و زينيكال اكتشفو انه ليه تاثير مضر ع الكبد
وغير كده انا جمعتهم كلهم
لعلاج الهشاشة ممكن يسبب هشاشة !!!!Bisphosphonates(fosamax) (10/13/2010)
The U.S. Food and Drug Administration (FDA) is updating the public regarding information previously communicated describing the risk of atypical fractures of the thigh, known as subtrochanteric and diaphyseal femur fractures, in patients who take bisphosphonates for osteoporosis. This information will be added to the Warnings and Precautions section of the labels of all bisphosphonate drugs approved for the prevention or treatment of osteoporosis.
اتسحبMeridia (sibutramine) (10/8/2010)
The U.S. Food and Drug Administration (FDA) is recommending against continued prescribing and use of Meridia (sibutramine) because this drug may pose unnecessary cardiovascular risks to patients. FDA has requested that Abbott Laboratories—the manufacturer of Meridia—voluntarily withdraw this drug product from the United States market. Abbott has agreed to voluntarily stop marketing of Meridia in the United States.
Lamictal (8/12/2010)
The U.S. Food and Drug Administration (FDA) is informing the public that Lamictal (lamotrigine)†, a medication commonly used for seizures in children two years and older, and bipolar disorder in adults, can cause aseptic meningitis. FDA is revising the Warnings and Precautions section of the drug label and the patient Medication Guide to include information about this risk.
اتسحب فى مصر Xenical (5/26/2010)
The U.S. Food and Drug Administration (FDA) has approved a revised label for Xenical to include new safety information about cases of severe liver injury that have been reported rarely with the use of this medication. The agency is also adding a new warning about rare reports of severe liver injury to the OTC Drug Facts label for Alli and is working with the manufacturer to ensure that consumers can understand this new warning.
بعد استخدام اكتر من سنة ممكن يسبب هشاشةProton pump inhibitors (05-25-2010)
The U.S. Food and Drug Administration (FDA) is revising the prescription and over-the-counter (OTC) labels for a class of drugs called proton pump inhibitors to include new safety information about a possible increased risk of fractures of the hip, wrist, and spine with the use of these medications.The new safety information is based on FDA's review of several epidemiological studies that reported an increased risk of fractures of the hip, wrist, and spine with proton pump inhibitor use. Some studies found that those at greatest risk for these fractures received high doses of proton pump inhibitors or used them for one year or more.
Prepared & collected by Dr M .Gomaa from FDA official website.
